Delivery Order SPE2DB25D3005-SPE2DB25FQJPF
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,846.97 on July 28, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a completion deadline of August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price contract is classified as a non-set-aside and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 18, 2025, to be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsules (30-count unit dose packaging) on September 8, 2025, with completion targeted for September 29, 2025. This non-set-aside contract was competitively awarded and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $27,693.94 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count). The contract, which is not set-aside and competitively awarded, specifies an ultimate completion date of September 24, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packages of 30 count. This is a firm fixed price delivery order with a ceiling value of $27,693.94 and an ultimate completion date of September 16, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $13,846.97 to AmerisourceBergen Drug Corp for Vyndamax 61 mg capsule unit dose packs (30-count) on August 27, 2025, with an ultimate completion date of September 18, 2025. The contract is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30-count). This competitively awarded, non-set-aside contract carries a ceiling value of $13,846.97 and employs firm fixed pricing. The delivery order is set for ultimate completion by September 15, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Vyndamax 61 mg capsules in unit dose packaging (30 count). The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of October 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $13,846.97 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Vyndamax 61 mg capsules in unit-dose packaging (30-count). The contract, with an ultimate completion date of August 12, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This competitively...
- SPE2DB25D3005Indefinite Delivery Contract
- SPE2DB25D3005-SPE2DB25FQJPFDelivery Order
The Defense Logistics Agency awarded a $13,846.97 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Vyndamax 61 mg capsule unit dose packages (30-count) with a firm fixed price structure. The contract, which is not set-aside, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 30, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal vendor for military and veteran healthcare systems. The company's substantial IDC with DLA enables it to supply a broad range of pharmaceutical products, medical supplies, vaccines, and specialty medications to support military healthcare programs globally, including services to the Defense Health Agency and U.S. Coast Guard. This particular delivery order for Vyndamax, a medication used to treat transthyretin amyloidosis, represents one of numerous competitively awarded transactions demonstrating the contractor's capability to fulfill diverse federal medical supply requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.8k | 9/9/25 |